D3 RECEPTOR LIGANDS AS TOOLS FOR IN VIVO INVESTIGATION IN MODELS OF DRUG ABUSE

D3 受体配体作为药物滥用模型体内研究的工具

• 批准号: 7562084
• 负责人: Amy Hauck Newman
• 金额: $ 0.53万
• 依托单位: HARVARD MEDICAL SCHOOL
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-05-01 至 2008-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7562084
• 关键词: Behavioral; Computer Retrieval of Information on Scientific Projects Database; Disease; Drug abuse; Funding; Grant; Institution; Investigation; Ligands; Modeling; Molecular; Research; Research Personnel; Resources; Source; Substance abuse problem; United States National Institutes of Health; dopamine D3 receptor; in vivo; receptor; tool

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This project seeks to identify and characertize at the molecular through behavioral levels the potential utility of selective dopamine D3 receptor ligands as candidate treatments for substance abuse disorders.

该子项目是利用该技术的众多研究子项目之一 资源由 NIH/NCRR 资助的中心拨款提供。子项目和 研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金， 因此可以在其他 CRISP 条目中表示。列出的机构是 对于中心来说，它不一定是研究者的机构。 该项目旨在通过行为水平在分子水平上识别和表征选择性多巴胺 D3 受体配体作为药物滥用障碍候选治疗的潜在效用。